Needham Downgrades Boston Scientific to Hold, Maintains Price Target to $86

Benzinga · 10/18 09:32
Needham analyst Mike Matson downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and maintains the price target from $86 to $86.